Brilacidin is an investigational polymer-based antibiotic, often classified as a defensin mimetic, currently undergoing development for the treatment of various bacterial infections. This category features… Read more
Brilacidin is an investigational polymer-based antibiotic, often classified as a defensin mimetic, currently undergoing development for the treatment of various bacterial infections. This category features essential reference materials required for rigorous pharmaceutical analysis, including Brilacidin API and its associated impurities, metabolites, and stable isotope labelled compounds. Analytical laboratories utilize these high-quality standards to conduct precise impurity profiling, method validation, and stability testing throughout the drug development lifecycle. By providing consistent reference points for mass spectrometry and NMR analysis, these compounds ensure the accurate identification and quantification of chemical constituents. Access to reliable reference standards and labelled versions, such as the 15N4-labelled compound, supports the stringent quality control protocols necessary for verifying the purity and safety of this therapeutic agent as it moves through clinical evaluation.